Article | Published:

Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme

Nature volume 445, pages 5357 (04 January 2007) | Download Citation

Subjects

Abstract

Protein phosphatase 2A (PP2A) is a principal Ser/Thr phosphatase, the deregulation of which is associated with multiple human cancers, Alzheimer’s disease and increased susceptibility to pathogen infections. How PP2A is structurally organized and functionally regulated remains unclear. Here we report the crystal structure of an AB′C heterotrimeric PP2A holoenzyme. The structure reveals that the HEAT repeats of the scaffold A subunit form a horseshoe-shaped fold, holding the catalytic C and regulatory B′ subunits together on the same side. The regulatory B′ subunit forms pseudo-HEAT repeats and interacts with the C subunit near the active site, thereby defining substrate specificity. The methylated carboxy-terminal tail of the C subunit interacts with a highly negatively charged region at the interface between A and B′ subunits, suggesting that the C-terminal carboxyl methylation of the C subunit promotes B′ subunit recruitment by neutralizing charge repulsion. Together, our structural results establish a crucial foundation for understanding PP2A assembly, substrate recruitment and regulation.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Protein phosphatase 2A is required for the initiation of chromosomal DNA replication. Proc. Natl Acad. Sci. USA 95, 14693–14698 (1998)

  2. 2.

    et al. Serine/threonine protein phosphatases in the control of cell function. Adv. Enzyme Regul. 34, 199–224 (1994)

  3. 3.

    Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell. Signal. 13, 7–16 (2001)

  4. 4.

    & Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353, 417–439 (2001)

  5. 5.

    Protein phosphatase 2A: who shall regulate the regulator?. Biochem. Pharmacol. 57, 321–328 (1999)

  6. 6.

    Protein phosphatase 2A: a panoply of enzymes. Curr. Opin. Cell Biol. 12, 180–185 (2000)

  7. 7.

    , & Protein phosphatase 2A subunit assembly: the catalytic subunit carboxy terminus is important for binding cellular B subunit but not polyomavirus middle tumor antigen. Oncogene 15, 911–917 (1997)

  8. 8.

    , , & Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits. EMBO J. 19, 5682–5691 (2000)

  9. 9.

    et al. Carboxyl methylation of the phosphoprotein phosphatase 2A catalytic subunit promotes its functional association with regulatory subunits in vivo.. EMBO J. 19, 5672–5681 (2000)

  10. 10.

    et al. Methylation of the protein phosphatase 2A catalytic subunit is essential for association of Bα regulatory subunit but not SG2NA, striatin, or polyomavirus middle tumor antigen. Mol. Biol. Cell 12, 185–199 (2001)

  11. 11.

    et al. Carboxymethylation of the PP2A catalytic subunit in Saccharomyces cerevisiae is required for efficient interaction with the B-type subunits Cdc55p and Rts1p. J. Biol. Chem. 276, 1570–1577 (2001)

  12. 12.

    , , , & Differential methylation and altered conformation of cytoplasmic and nuclear forms of protein phosphatase 2A during cell cycle progression. J. Cell Biol. 129, 397–410 (1995)

  13. 13.

    et al. Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J. Neuropathol. Exp. Neurol. 63, 1080–1091 (2004)

  14. 14.

    , & PP2A: the expected tumor suppressor. Curr. Opin. Genet. Dev. 15, 34–41 (2005)

  15. 15.

    , & B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK. EMBO J. 25, 727–738 (2006)

  16. 16.

    et al. A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation. EMBO J. 19, 562–571 (2000)

  17. 17.

    et al. Regulation of β-catenin signaling by the B56 subunit of protein phosphatase 2A. Science 283, 2089–2091 (1999)

  18. 18.

    & Identification of a new family of protein phosphatase 2A regulatory subunits. J. Biol. Chem. 270, 26123–26128 (1995)

  19. 19.

    et al. Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 5, 127–136 (2004)

  20. 20.

    & ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia. Br. J. Cancer 95, 775–781 (2006)

  21. 21.

    et al. Three-dimensional structure of the catalytic subunit of protein serine/threonine phosphatase-1. Nature 376, 745–753 (1995)

  22. 22.

    , , , & The structure of the protein phosphatase 2A PR65/A subunit reveals the conformation of its 15 tandemly repeated HEAT motifs. Cell 96, 99–110 (1999)

  23. 23.

    et al. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12–FK506 complex. Cell 82, 507–522 (1995)

  24. 24.

    , , & A metal-dependent form of protein phosphatase 2A. Biochem. Biophys. Res. Commun. 208, 274–279 (1995)

  25. 25.

    , , , & Separation of PP2A core enzyme and holoenzyme with monoclonal antibodies against the regulatory A subunit: abundant expression of both forms in cells. Mol. Cell. Biol. 17, 1692–1701 (1997)

  26. 26.

    et al. Identification of binding sites on the regulatory A subunit of protein phosphatase 2A for the catalytic C subunit and for tumor antigens of simian virus 40 and polyomavirus. Mol. Cell. Biol. 12, 4872–4882 (1992)

  27. 27.

    , & Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the Aα subunit gene. Oncogene 20, 10–15 (2001)

  28. 28.

    , , , & Modulation of the enzymatic properties of protein phosphatase 2A catalytic subunit by the recombinant 65-kDa regulatory subunit PR65α. Eur. J. Biochem. 248, 200–208 (1997)

  29. 29.

    et al. Alterations of the PPP2R1B gene in human lung and colon cancer. Science 282, 284–287 (1998)

  30. 30.

    , & Binding specificity of protein phosphatase 2A core enzyme for regulatory B subunits and T antigens. J. Virol. 73, 839–842 (1999)

  31. 31.

    , , , & Baculovirus expression, purification, and characterization of human protein phosphatase 2A catalytic subunits α and β. Protein Expr. Purif. 45, 150–156 (2006)

  32. 32.

    Methotrexate and Ras methylation: a new trick for an old drug?. Sci. STKE 2004, pe13 (2004)

  33. 33.

    , & Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 257, 1261–1264 (1992)

  34. 34.

    & Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997)

  35. 35.

    et al. The use of SnB to determine an anomalous scattering substructure. Acta Crystallogr. D 54, 799–804 (1998)

  36. 36.

    & Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. Methods Enzymol. 276, 472–494 (1997)

  37. 37.

    DM: an automated procedure for phase improvement by density modification. Joint CCP4 ESF-EACBM Newsl. Prot. Crystallogr. 31, 34–38 (1994)

  38. 38.

    XtalView/Xfit–A versatile program for manipulating atomic coordinates and electron density. J. Struct. Biol. 125, 156–165 (1999)

  39. 39.

    & Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126–2132 (2004)

  40. 40.

    , , , & Efficient anisotropic refinement of macromolecular structures using FFT. Acta Crystallogr. D 55, 247–255 (1999)

Download references

Acknowledgements

We thank S. Morrone, F. Gao and other laboratory members and rotation students for help with this work. We are grateful to J. Abendroth for advice on crystallographic computation, and the staff at ALS beamline 5.0.2 for assistance with data collection. We also thank D. Virshup and X. Liu for B56 cDNAs, and N. Zheng, D. Virshup and E. Ogris for critical comments on this manuscript. This work was supported in part by an Investigator’s Award from the Burroughs Welcome Fund to W.X. and by the Keck Center for Pathogenesis at the University of Washington.

Author information

Affiliations

  1. Department of Biological Structure, University of Washington, Seattle, Washington 98195, USA

    • Uhn Soo Cho
    •  & Wenqing Xu

Authors

  1. Search for Uhn Soo Cho in:

  2. Search for Wenqing Xu in:

Competing interests

Coordinates and structure factors are deposited in the Protein Data Bank under accession code 2IAE. Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.

Corresponding author

Correspondence to Wenqing Xu.

Supplementary information

PDF files

  1. 1.

    Supplementary Notes

    This file contains the Supplementary Methods, Supplementary Figures 1–9 and additional references. The Supplementary Methods describes the detailed methods of protein purification, crystallization, and structural determination.

  2. 2.

    Supplementary Table

    This table contains the summary of crystallographic analysis.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nature05351

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.